| 臺大學術典藏 |
2018-09-10T06:15:06Z |
Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer
|
Lee, Y.-C. and Lin, J.-T. and Wu, H.-M. and Liu, T.-Y. and Yen, M.-F. and Chiu, H.-M. and Wang, H.-P. and Wu, M.-S. and Chen, T.H.-H.; HAN-MO CHIU; HSIU-HSI CHEN; YI-CHIA LEE; MING-SHIANG WU |
| 臺大學術典藏 |
2020-11-02T02:05:09Z |
Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer
|
Chen T.H.-H.; MING-SHIANG WU; Wang H.-P.; Chiu H.-M.; Yen M.-F.; Lee Y.-C.; Lin J.-T.; Wu H.-M.; Liu T.-Y. |
| 臺大學術典藏 |
2021-02-03T03:56:50Z |
Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer
|
Lee Y.-C.; Lin J.-T.; Wu H.-M.; Liu T.-Y.; Yen M.-F.; HAN-MO CHIU; Wang H.-P.; Wu M.-S.; Chen T.H.-H. |
| 臺大學術典藏 |
2021-01-15T03:47:26Z |
Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer
|
Lee Y.-C.; Lin J.-T.; Wu H.-M.; Liu T.-Y.; Yen M.-F.; Chiu H.-M.; HSIU-PO WANG; Wu M.-S.; Chen T.H.-H. |
| 臺大學術典藏 |
2021-02-02T05:45:44Z |
Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer
|
Yi-Chia Lee;Lin J.-T.;Wu H.-M.;Liu T.-Y.;Yen M.-F.;Chiu H.-M.;Wang H.-P.;Wu M.-S.;Chen T.H.-H.; YI-CHIA LEE; Lin J.-T.; Wu H.-M.; Liu T.-Y.; Yen M.-F.; Chiu H.-M.; Wang H.-P.; Wu M.-S.; Chen T.H.-H. |
| 臺大學術典藏 |
2022-04-21T06:51:22Z |
Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer
|
Lee Y.-C.; Lin J.-T.; Wu H.-M.; Liu T.-Y.; Yen M.-F.; Chiu H.-M.; Wang H.-P.; Wu M.-S.; Chen, Tony Hsiu Hsi |
| 臺大學術典藏 |
2022-09-06T07:43:42Z |
Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer
|
Lee Y.-C.; Lin J.-T.; Wu H.-M.; Liu T.-Y.; Yen M.-F.; Chiu H.-M.; Wang H.-P.; MING-SHIANG WU; Chen T.H.-H. |
| 臺大學術典藏 |
2022-09-07T06:50:43Z |
Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer
|
YI-CHIA LEE; Lin J.-T.; Wu H.-M.; Liu T.-Y.; Yen M.-F.; Chiu H.-M.; Wang H.-P.; Wu M.-S.; Chen T.H.-H. |
| 國立臺灣大學 |
2007 |
Cost-Effectiveness Analysis for Determining Optimal Cut-Off of Immunochemical Faecal Occult Blood Test for Population-Based Colorectal Cancer Screening (Kcis 16)
|
陳立昇; 廖朝聖; 張淑惠; 賴信志; 陳秀熙; CHEN, LI-SHENG; LIAO, CHAO-SHENG; CHANG, SHU-HUI; LAI, HSIN-CHIH; CHEN, TONY HSIU-HIS |
| 臺大學術典藏 |
2018-09-10T06:15:43Z |
Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16)
|
Chen, L.-S.;Liao, C.-S.;Chang, S.-H.;Lai, H.-C.;Chen, T.H.-H.; SHU-HUI CHANG; HSIU-HSI CHEN |
| 臺大學術典藏 |
2022-04-21T06:51:17Z |
Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16)
|
Chen L.-S.; Liao C.-S.; Chang S.-H.; Lai H.-C.; Chen, Tony Hsiu Hsi |
| 臺大學術典藏 |
2022-05-03T06:19:32Z |
Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16)
|
Chen L.-S.; Liao C.-S.; SHU-HUI CHANG; Lai H.-C.; Chen T.H.-H. |
| 臺北醫學大學 |
2011 |
Cost-Effectiveness Analysis for Pap Smear Screening and Human Papillomavirus DNA Testing and Vaccination
|
MK, Chen;HF, Hung;SW, Duffy;AMF, Yen;HH, Chen |
| 臺北醫學大學 |
2011 |
Cost-Effectiveness Analysis for Pap Smear Screening and Human Papillomavirus DNA Testing and Vaccination
|
Chen, MK;Hung, HF;Duffy, SW;AMF, Yen;Chen, HH |
| 臺大學術典藏 |
2022-04-21T06:50:57Z |
Cost-effectiveness analysis for Pap smear screening and human papillomavirus DNA testing and vaccination
|
Chen M.-K.; Hung H.-F.; Duffy S.; Yen A.M.-F.; Chen, Tony Hsiu Hsi |
| 衛生福利部國家中醫藥研究所 |
2018 |
Cost-effectiveness analysis of a fixed-dose combination of indacaterol and glycopyrronium as maintenance treatment for COPD
|
Chan, Ming-Cheng;Tan, Elise Chia-Hui;Yang, Ming-Chin |
| 臺大學術典藏 |
2019-07-16T05:34:46Z |
Cost-effectiveness analysis of a fixed-dose combination of indacaterol and glycopyrronium as maintenance treatment for COPD
|
Chan M.-C.;Tan E.C.-H.;Ming-Chin Yang; Chan M.-C.; Tan E.C.-H.; MING-CHIN YANG |
| 臺北醫學大學 |
2012-06-27 |
Cost-effectiveness analysis of antiemetic regimen containing aprepitant as first-line prophylaxis for high dose cisplatin-based chemotherapy induced emesis, a pilot study
|
Kok, Chin-Yee; 郭沁怡 |
| 國立臺北護理健康大學 |
2017-03 |
Cost-Effectiveness Analysis of Apixaban, Dabigatran, Rivaroxaban and Warfarin for Stroke Prevention in Atrial Fibrillation in Taiwan
|
Liu, Chieh Yu;Chen, Hui Chun |
| 國立臺北護理健康大學 |
2017-03 |
Cost-Effectiveness Analysis of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation in Taiwan
|
Liu, Chieh-Yu; Chen, Hui-Chun |
| 國家衛生研究院 |
2024-01 |
Cost-effectiveness analysis of cell-based versus egg-based quadrivalent influenza vaccines in the pediatric population in Taiwan
|
Chi, CY;Cheng, MF;Ko, K;Mould, JF;Chen, CJ;Huang, YC;Lee, PI |
| 臺北醫學大學 |
2012-06-20 |
Cost-Effectiveness Analysis of Cervical Cancer Screening Supplemented with Self-Sampling for Human Papillomavirus DNA Testing in Taiwan
|
Tsai, Ping-Ching; 蔡秉磬 |
| 臺北醫學大學 |
2018 |
Cost-effectiveness analysis of chronic opioid therapy for chronic noncancer pain patients
|
Huang, Xue-Lun; 黃學論 |
| 國立臺灣大學 |
2006 |
COST-EFFECTIVENESS ANALYSIS OF COLORECTAL CANCER SCREENING WITH STOOL DNA TESTING IN INTERMEDIATE- INCIDENCE COUNTRIES
|
WU, GRACE, HUI-MIN; WANG, YI-MING; YEN, AMY, MING-FANG; WONG, JAU-MIN; LAI, HSIN-CHIH; CHEN, TONY, HSIU-HIS; 吳慧敏; 王怡敏; 嚴明芳; 翁昭旼; 賴信志; 陳秀熙 |
| 國立臺灣大學 |
2006 |
Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries
|
Wu, Grace Hui-Min; Wang, Yi-Ming; Yen, Amy Ming-Fang; Wong, Jau-Min; Lai, Hsin-Chih; Warwick, Jane; Chen, Tony Hsiu-Hsi |
